Clinical Trial Update: The Impact of Proton Pump Inhibitors on the Fecal Microbiome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial, sponsored by Mayo Clinic, investigates how proton pump inhibitors affect the fecal microbiome, including healthy volunteers and patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Snippet

Sponsor: Mayo Clinic | Conditions: Healthy, Clostridium Difficile Infection | Phase 1 | Status: COMPLETED